Aloe vera ( DrugBank: Aloe, Aloe vera )

3 diseases

ID	Disease name (Link within this page)	Number of trials
53	Sjogren syndrome	1
97	Ulcerative colitis	2
226	Interstitial cystitis with Hunners ulcer	1

53. Sjogren syndrome

Clinical trials : 283 / Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04252209 (ClinicalTrials.gov)	August 2021	26/1/2020	the Effect of Mixture of Natural Products As Salivary Substitutes in Treatment Of Xerostomia	the Effect of Mixture of Natural Products As Salivary Substitute In Comparison To Carboxy Methyl Cellulose In Treatment Of Xerostomia In Patients With Sjogren's Syndrome: Cross Over Randomized Clinical Trial	Sjogren's Syndrome;Xerostomia	Other: natural herbs of coconut, aloe vera, and pepperint;Other: carboxy methyl cellulose	Cairo University	NULL	Not yet recruiting	18 Years	80 Years	All	44	Phase 3	NULL

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01783119 (ClinicalTrials.gov)	August 2012	31/1/2013	Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis	Effect of Aloe Vera in the Inflammation of Patients With Mild Ulcerative Colitis	Ulcerative Colitis	Dietary Supplement: Aloe Barbadensis Miller;Dietary Supplement: placebo water	National Institute of Medical Sciences and Nutrition, Salvador Zubiran	NULL	Recruiting	18 Years	59 Years	Both	60	Phase 0	Mexico
2	NCT04753775 (ClinicalTrials.gov)	March 10, 2010	9/2/2021	RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.	RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ENEMA ALOE VERA GEL FOR ACHIVING REMISSION IN ACTIVE ULCERATIVE PROCTOSIGMOIDITIS.	Aloe Vera Gel, Proctosigmoiditis, Remission, Trial, Ulcerative Colitis (UC)	Drug: Aloe vera gel	Ospedale Sandro Pertini, Roma	NULL	Completed	18 Years	N/A	All	44	N/A	NULL

Clinical trials : 143 / Drugs : 171 - (DrugBank : 56) / Drug target genes : 64 - Drug target pathways : 145

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04734106 (ClinicalTrials.gov)	May 2022	27/1/2021	Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis	A Double-Blind, Placebo-Controlled Study to Establish the Safety and Efficacy of Super-Concentrated, Freeze-Dried Aloe Vera in the Management of the Symptoms of Interstitial Cystitis	Interstitial Cystitis;Chronic Interstitial Cystitis;Bladder Pain Syndrome	Drug: Desert Harvest Aloe Vera Capsules;Other: Placebo Capsules	Wake Forest University Health Sciences	Desert Harvest	Not yet recruiting	18 Years	N/A	All	100	Early Phase 1	United States